Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN (Q34164223)

31 July 2017

Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN (English)

1 reference

31 July 2017

J Cunha-Cruz

2

0 references

Monika M Safford

23

object named as

Monika Safford

1 reference

31 July 2017

A Barasch

1

1 reference

31 July 2017

F A Curro

3

1 reference

31 July 2017

P Hujoel

4

1 reference

31 July 2017

A H Sung

5

1 reference

31 July 2017

D Vena

6

1 reference

31 July 2017

A E Voinea-Griffin

7

1 reference

31 July 2017

CONDOR Collaborative Group

8

1 reference

31 July 2017

Steven Beadnell

9

1 reference

31 July 2017

Ronald G Craig

10

1 reference

31 July 2017

Timothy DeRouen

11

1 reference

31 July 2017

Ananda Desaranayake

12

1 reference

31 July 2017

Ann Gilbert

13

1 reference

31 July 2017

Gregg H Gilbert

14

1 reference

31 July 2017

Ken Goldberg

15

1 reference

31 July 2017

Richard Hauley

16

1 reference

31 July 2017

Mariko Hashimoto

17

1 reference

31 July 2017

Jon Holmes

18

1 reference

31 July 2017

Brooke Latzke

19

1 reference

31 July 2017

Brian Leroux

20

1 reference

31 July 2017

Anne Lindblad

21

1 reference

31 July 2017

Joshua Richman

22

1 reference

31 July 2017

Jonathan Ship

24

1 reference

31 July 2017

Van P Thompson

25

1 reference

31 July 2017

O Dale Williams

26

1 reference

31 July 2017

Wanrong Yin

27

1 reference

31 July 2017

language of work or name

English

0 references

publication date

11 February 2011

1 reference

Journal of Dental Research

31 July 2017

1 reference

31 July 2017

90

1 reference

31 July 2017

4

1 reference

31 July 2017

439-444

1 reference

Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Recent developments in bisphosphonate therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Changes in coagulation and fibrinolysis of post-SARS osteonecrosis in a Chinese population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Radiotherapy-induced mandibular bone complications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Oro-facial gangrene (noma/cancrum oris): pathogenetic mechanisms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Treatment of bone diseases with bisphosphonates, excluding osteoporosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144129

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

5 July 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034510397196

Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034510397196

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034510397196

Possible association between diabetes and bisphosphonate-related jaw osteonecrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034510397196

A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034510397196

National trends in osteoporosis visits and osteoporosis treatment, 1988-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034510397196

Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034510397196

Avascular necrosis of the jaws: risk factors in metastatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034510397196

Osteonecrosis of the jaws associated with cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034510397196

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034510397196

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034510397196

Bisphosphonates for care and cure

21 January 2018

1 reference

12 December 2020

Tooth exfoliation, osteonecrosis of the jaw and neuralgia following herpes zoster of the trigeminal nerve

1 reference

12 December 2020

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

Avascular necrosis and protease inhibitors

1 reference

12 December 2020

Identifiers

DOI

10.1177/0022034510397196

1 reference

31 July 2017

1 reference

31 July 2017

1 reference